| CTRI Number |
CTRI/2024/03/063857 [Registered on: 08/03/2024] Trial Registered Prospectively |
| Last Modified On: |
20/02/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug |
| Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
|
Public Title of Study
|
To compare the pain score after operation in patients undergoing laminectomy surgeries by spraying buprenorphine and saline in epidural space |
|
Scientific Title of Study
|
A RANDOMIZED DOUBLE BLINDED
COMPARITIVE STUDY OF INSTILLATION OF
BUPRENORPHINE VS PLACEBO IN EPIDURAL
SPACE FOR POSTOPERATIVE ANALGESIA IN
POST LAMINECTOMY PATIENTS |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Yoganarasimha N |
| Designation |
Professor |
| Affiliation |
BGS Global Institute of Medical Sciences |
| Address |
Department of Anaesthesiology, BGS Global Institute of Medical Sciences, Uttarahalli Main Road, Kengeri, Bangalore
Bangalore KARNATAKA 560060 India |
| Phone |
9845365348 |
| Fax |
|
| Email |
yogabmc98@yahoo.co.in |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Chandana P |
| Designation |
Assistant Professor |
| Affiliation |
BGS Global Institute of Medical Sciences |
| Address |
Department of Anaesthesiology, BGS Global Institute of Medical Sciences, Uttarahalli Main Road, Kengeri, Bangalore
Bangalore KARNATAKA 560060 India |
| Phone |
9980933692 |
| Fax |
|
| Email |
drchandana.chandana@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Amrutha H A |
| Designation |
Post-graduate |
| Affiliation |
BGS Global Institute of Medical Sciences |
| Address |
Department of Anaesthesiology, BGS Global Institute of Medical Sciences, Uttarahalli Main Road, Kengeri, Bangalore
Bangalore KARNATAKA 560060 India |
| Phone |
9738556636 |
| Fax |
|
| Email |
haamrutha21@gmail.com |
|
|
Source of Monetary or Material Support
|
| BGS Global Institute of Medical Sciences, Uttarahalli main road, Kengeri, Bangalore |
|
|
Primary Sponsor
|
| Name |
Department of Anaesthesiology |
| Address |
BGS Global Institute of Medical Sciences, Uttarahalli Main Road, Kengeri, Bangalore |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Yoganarasimha N |
BGS Global Institute of Medical Sciences |
Professor, Department of anaesthesia, BGS Global Institute of Medical Sciences, Uttarahalli main road, Kengeri, Bangalore Bangalore KARNATAKA |
9845365348
yogabmc98@yahoo.co.in |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| BGS Global Institute Of Medical Sciences |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: G952||Other and unspecified cord compression, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Inj Buprenorphine |
300mcg, Diluted to 10ml Instilled into epidural space, 3 mins |
| Comparator Agent |
Placebo (Normal saline) |
10ml, instilled into epidural space, 3 mins |
|
|
Inclusion Criteria
|
| Age From |
20.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Patients willing to give informed and written consent
ASA physical status I & II
Patients with body weight 50-80kgs
|
|
| ExclusionCriteria |
| Details |
ASA physical status III and above.
Patients who have known hypersensitivity to the study drugs
Patients with history of neuromuscular disease
Patients with history of substance abuse
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
|
|
Blinding/Masking
|
|
|
Primary Outcome
|
| Outcome |
TimePoints |
Pain by Numerical pain rating scale
|
1st, 2nd, 3rd, 4th, 5th, 6th, 12th, 18th and 24 hours |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
Pulse Rate
Mean Arterial Pressure
Respiratory Rate
SpO2
|
1st, 2nd, 3rd, 4th, 5th, 6th, 12th, 18th and 24 hours |
|
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3/ Phase 4 |
|
Date of First Enrollment (India)
|
20/03/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Clinical Study Report
- Who will be able to view these files?
Response - Researchers who provide a methodologically sound proposal.
- For what types of analyses will this data be available?
Response - Any purpose.
- By what mechanism will data be made available?
Response (Others) -
- For how long will this data be available start date provided 01-04-2024 and end date provided 21-07-2084?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
|
Brief Summary
|
Immediate postoperative pain relief after
surgery can significantly affect the outcome of surgical procedures and
operative morbidity. Parenteral opioids are the mainstay of treatment for postoperative pain
after laminectomy. But these are usually given with large time lapses which
cause fluctuations in clinical effect. The epidural injection of opioids has
proven to be effective and has a longer duration of action in relieving
postoperative pain. Postoperative pain management for
spinal surgery with epidural infusion of morphine and fentanyl has been widely
reported. Buprenorphine,
because it is more potent and more lipid-soluble and has a longer duration of
action, is said to have advantages over morphine for epidural use in
postoperative pain relief. |